Jupiter Neurosciences Inc. Insider Trading

JUNS

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jul 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jul 2025

Jul 1, 2025

Get an email when JUNS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 1, 2025	Alison D. Silva Pres + Chief Business Officer	Bought 3 parts	750	$1.03 average	$773	0.7%	Form 4
Jul 1, 2025	Christer Rosen CEO and Chairman	Bought 2 parts	3,600	$1.02 average	4K	<0.1%	Form 4
Jun 27, 2025 – Jun 30, 2025	Alison D. Silva Pres + Chief Business Officer	Bought 9 parts	1,800	$1.03 average	2K	1.6%	Form 4
Jun 27, 2025 – Jun 30, 2025	Christer Rosen CEO and Chairman	Bought 7 parts	7,816	$1.02 average	8K	<0.1%	Form 4

Jul 1, 2025
Alison D. Silva
Pres + Chief Business Officer · bought 750 at avg $1.03
$773
0.7% of stake
Jul 1, 2025
Christer Rosen
CEO and Chairman · bought 3,600 at avg $1.02
4K
<0.1% of stake
Jun 27, 2025 – Jun 30, 2025
Alison D. Silva
Pres + Chief Business Officer · bought 1,800 at avg $1.03
2K
1.6% of stake
Jun 27, 2025 – Jun 30, 2025
Christer Rosen
CEO and Chairman · bought 7,816 at avg $1.02
8K
<0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch JUNS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with JUNS

CompareIntrinsic value

SKVISkinvisible Inc.

$0.16+0.00%0

BDPTBioadaptives Inc.

$0.00-5.88%25

LYELLyell Immunopharma, Inc.

$15.43+43.27%10

ADTXAditxt Inc.

$0.00+33.33%20

IBOImpact Biomedical Inc.

$4.10+1.99%20

GNLXGenelux Corp.

$1.96+2.08%10

ASBPAspire Biopharma Holdings Inc.

$7.27-0.41%20

NTHINeonC Technologies Holdings

$3.17+3.26%10

Spot a number that looks wrong? Check it in JUNS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing JUNS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.